Patients' preferences for adjuvant chemotherapy in early breast cancer: a review of what makes it worthwhile?
- 1 November 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (11) , 691-697
- https://doi.org/10.1016/s1470-2045(01)00559-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Patient Preferences for Adjuvant Chemotherapy of Early Breast Cancer: How Much Benefit Is Needed?JNCI Monographs, 2001
- Adjuvant Therapy for All Patients With Breast Cancer?JNCI Journal of the National Cancer Institute, 2001
- Framing of outcome and probability of recurrence: Breast cancer patients' choice of adjuvant chemotherapy (ACT) in hypothetical patient scenariosBreast Cancer Research and Treatment, 2000
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.Journal of Clinical Oncology, 1998
- Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.Journal of Clinical Oncology, 1998
- On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993Annals of Oncology, 1996
- Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer.Journal of Clinical Oncology, 1995
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.BMJ, 1990
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983